Skip to Content

How do you think the launch of Onglyza will pan out in India?

Responses (1)

Rajive Goel 5 Jan 2012

Depending upon the pricing structure & availability of Saxagliptin (Onglyza) the pill should do well in India, as India happens to be perhaps the capital of diabetics.

India is the perhaps the first Asian country where saxagliptin is available, launched by Bristol-Myers Squibb and AstraZeneca. free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Similar Questions